Management of HCV after therapy has complexity if patients continue to engage in high risk activities, are at risk for advanced liver disease progression or have failed first line therapy.
Tuesday, 1:00pm - Tuesday, 2:00pm
Despite emerging data on early liver transplant as salvage therapy for severe alcoholic hepatitis, barriers remain on the acceptance of this option in the routine clinical care of these patients.
Wednesday, 9:00am - Wednesday, 10:00am
This webinar will review the latest approaches in the management of the immunosuppressed patient in the context of HBV reactivation, including screening, risk stratification and indication for antiviral treatment.
Thursday, 1:00pm - Thursday, 2:00pm
The conference will focus on genomics and the changing approach to diagnostics, management and research in adult and pediatric liver diseases.
Friday, 8:00am - Saturday, 11:15am